LICE TREATMENT MARKET ANALYSIS

Market News

Global Lice Treatment Market: Key Developments

 In February 2021, Benchmark-  an aquaculture biotechnology company, planned to launch its novel lice treatment. Large-scale trials of Benchmark’s BMK08 medicine and the CleanTreat filtering system have proved the combination to be extremely effective against lice without impacting the environment.

In October 2020, KAKEN PHARMACEUTICAL CO., LTD.- an R&D-driven pharmaceutical company focusing on dermatology and orthopedics, and Arbor Pharmaceuticals (A subsidiary of Azurity Pharmaceuticals, Inc.)- specialty pharmaceutical company developing late-stage therapeutic products for common pediatric conditions, entered into a licensing agreement to develop and commercialize an anthelminthic agent ivermectin lotion, 0.5% Sklice Lotion, for the treatment of head lice, a parasitic infectious disease, in Japan.

According to  a study published by The World Health Organization (WHO) on May 31, 2023, globally, it is estimated to affect more than 200 million people at any time and more than 400 million people cumulatively every year suffer from scabies. Scabies is one of the commonest dermatological conditions, accounting for a substantial proportion of skin disease in developing countries.

Global Lice Treatment Market: Key Trends

The rising incidences of mergers, acquisitions, and partnership scensrios is expected to boost the growth of global lice treatment . For instance, in July 2022, Piedmont Animal Health- an animal veterinary pharmaceutical company, was acquired by Dechra Pharmaceuticals- a business involved in the development and marketing of veterinary products based in Northwich, England.

The rising incidences of  research and development activities is expected to boost the growth of global lice treatment According to an article published in January 2020, in Frontiers-  an open access publisher of peer-reviewed scientific articles, whole genome sequencing of head lice belonging to different clades with integration of high-throughput technologies to study global changes in mRNA transcription, translation and computational approaches, will accelerate the addressing of important biological questions, identification, and exploitation of new target genes of this insect vector, insecticide discovery, as well as to develop novel therapies.